Proactiveinvestors Australia Holista Colltech Ltd Proactiveinvestors Australia Holista Colltech Ltd RSS feed en Thu, 20 Dec 2018 03:43:16 +1100 Genera CMS (Proactiveinvestors) (Proactiveinvestors) <![CDATA[News - Holista CollTech secures distribution rights for unique algae supplement ]]> Holista CollTech Limited (ASX:HCT) has secured the global distribution rights for a supplement, sourced from algae found in pristine conditions in a lake in the U.S., that can enhance stem cell growth.

The Aphanizomenon Flos-aquae (AFA) algae is harvested from Klamath Lake in Oregon, which is considered to be the most pristine environment in North America after Alaska.

When consumed, the Klamax™ algae supplement is believed to enhance general wellness and anti-aging health, by promoting and supporting a normal neurological, somatic and stem-cells physiology.

The algae’s unusual properties are due in part to the fact that it grows on the surface of the lake that sits on top of a 7,700-year bed of rich volcanic ash.

Developed by scientist Dr Stefano Scoglio, the product has a high concentration of a molecule endowed with neuromodulating, immune-enhancing and neuronal stem-cell promoting activities.

Holista intends to develop oral and transdermal preparations to be sold through network marketing platform, iGalen International Inc.

In September 2017, Holista announced that it was acquiring a 47% stake in iGalen from Dr Rajen Manicka for a nominal consideration of US$1 pending shareholder approval.

iGalen has more than 12,500 distributors worldwide, and intends to enter Australia and New Zealand, in addition to the U.S., Canada, Malaysia, Singapore and Philippines.

In August 2017, Holista had secured the global rights for Emulin®, an all-natural carbohydrates manager developed by two Nobel Prize nominees.

Tue, 14 Nov 2017 11:19:00 +1100
<![CDATA[News - Holista CollTech snaps up asset ]]> Holista Colltech Ltd (ASX:HCT) has pounced on an acquisition, and the ASX has granted the company a trading halt to prepare more details.

Holista provides first-class natural ingredients and wellness products.

The halt will remain in place until the opening of trade on Thursday 21st September 2017, or earlier if an announcement is made to the market.

Tue, 19 Sep 2017 11:14:00 +1000
<![CDATA[News - Holista CollTech to file patent for world’s first all-natural low-GI sugar ]]> Daryl Thompson is an emerging thought leader in carbohydrate chemistry who was nominated for the 2015 and 2016 Nobel Prize.

Holista’s shares were last trading at $0.135, up 28.6% intra-day.

The all-natural, low-GI sugar is the newest addition to Holista’s low-GI suite of products.

The formula is being refined before testing at the world renowned GI Labs in Toronto for final validation.

As the product is made from natural ingredients, it is unlikely to face regulatory hurdles.

Holista expects to launch the product before June 2017.

High-GI foods are rapidly and easily converted to sugar, causing spikes in blood sugar levels that can lead to heart disease, diabetes and obesity over time.

Unlike other alternatives which can only be used in beverages, such as artificial sweeteners, Holista’s natural low-GI sugar can be melted, baked and caramelized for use in all cooking applications.

When consumed, it reduces the rate that glucose is digested throughout the body.

A 2012 study in the highly acclaimed scientific journal Nature suggested that sugar should be considered as toxic as other substances harmful to public health, such as alcohol or tobacco.

The authors urged government regulation to curb consumption, including taxes, advertisement restrictions, and even age requirements for purchase of sugary foods.

Fri, 06 Jan 2017 12:00:00 +1100
<![CDATA[News - Holista CollTech teams with North American noodle manufacturer ]]> Holista Foods has developed PANATURA, a breakthrough natural formula which, when added to white flour, dramatically reduces blood sugar levels without changing the taste of the final product.

Based in Ontario and Alberta, Canada, Wing’s has supplied noodles to the North American market since 1953.

Wing’s will test Holista’s low-GI ingredient for use in noodles and Holista will provide expertise on the application of its formula.

The final product will be independently tested at GI-Labs, a nutrition research organization in Toronto, Canada.

Once validated, Wing’s and Holista Foods will enter a commercial agreement to manufacture and distribute the low-GI noodles in North America.

Holista Foods is a 51-49 joint-venture company set-up between Holista and Nadja Foods LLC.

According to market research group Statista, almost 50% of the world’s wheat is consumed as noodles, led by China and Indonesia, respectively.

In comparison, only a quarter of the world’s wheat is consumed as bread.

In 2015, the global demand for instant noodles amounted to 103.58 billion servings.

The low-GI movement is gaining traction as consumers are getting educated on making healthy food choices to tackle the global pandemic of obesity and diabetes.

Fri, 21 Oct 2016 10:00:00 +1100
<![CDATA[News - Holista Colltech Ltd and Nadja Piatka to promote low GI white bread ]]> Holista Colltech Ltd (ASX:HCT) and celebrity food expert Nadja Piatka will promote low-GI (glycemic index) foods in North America.

Holista and Nadja Foods have formed a 51-49 joint venture - Holista Foods, which will promote low-GI reducer for white bread and baked products across North America.

Nadja Piatka, a former guest on the Oprah Winfrey show and baked goods supplier to major food chains such as McDonald’s and Subway, will assume the post of CEO at Holista Foods.

Baked goods are the top source of high-GI foods in the modern diet. GI values indicate the rate and level at which different carbohydrate-based foods increase blood glucose and insulin.

The low-GI movement is gaining traction as consumers are getting educated on making healthy food choices and are waiting for products to meet this demand.

According to market research, North America is the world’s largest market for baked goods, estimated at US$37 billion and growing at 2% a year.

In addition to low-GI reducer for baked products, Holista has a suite of other ingredients including low sodium salt, low fat fried foods and low calorie sugar.


Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

Tue, 12 Jul 2016 11:30:00 +1000
<![CDATA[News - Holista CollTech to gain European bakery expert as shareholder ]]> Holista Colltech (ASX:HCT) will issue shares up to a 10% stake to the major shareholder of Swiss Panadoro Group and Matzingen-based Veripan AG, Europe’s largest independent supplier of specialty baking ingredients.

Holista, which recently announced a scientific breakthrough to make white bread healthier with its combination of a blend of okra, lentils, barley and fenugreek with Veripan’s sourdough formula to form PANATURA® GI, will sell shares and free attaching options to Meiert Grootes in tranches.

Grootes will acquire the shares at $0.115 amounting to A$454,734, via a direct placement, equal to a 2.5% holding.

Free attached options will be issued for 11,862,616 new shares, which will enlarge his stake in Holista by a further 7.5% exercisable at various strike prices.

Holista's patented formula scored a Glycemic Index (“GI”) reading of 53, the lowest-ever achieved by any clean-label white bread in a clinical trial.

It will begin marketing PANATURA® GI to the US$170 billion white bread market, a rollout in which Grootes will play a significant role given his 27 years’ experience in the bread industry and contacts in the milling and bakery industry.

Clearly, interesting times are ahead in the roll-out of the product.

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

Tue, 16 Feb 2016 16:00:00 +1100
<![CDATA[News - Holista CollTech cracks formula to produce white bread with low GI level ]]> Australian biotechnology company, Holista Colltech (ASX:HCT) has confirmed that a mix of natural ingredients has been shown to significantly reduce blood sugar levels caused by consuming white bread and other bakery products.

A clinical study on the ingredients was carried out at a leading Australian university in December 2015, with Hollista's proprietary GI Lite formulae and Veripan’s natural sourdough PANATURA® achieved a Glycemic Index (GI) reading of 53, the lowest level ever achieved worldwide in a clean-label white bread.

GI is an indicator of the ability of different types of foods that contain carbohydrate to raise the blood glucose.

A high GI score contain rapidly digested carbohydrates that can trigger a large and rapid rise in the level of blood glucose and potentially the insulin level.

Switzerland-based Veripan AG is Europe's largest independent supplier of specialty bakery ingredients.

The GI formulae, made from extracts of okra (ladies' fingers), dhal (lentils), barley and fenugreek – and Veripan’s natural sourdough PANATURA® provided the breakthrough.

The Australian university research team has been at the forefront of GI research for over a decade, and has determined the GI values of more than 2,500 foods.

Holista and Veripan will jointly distribute the PANATURA® GI which is believed to be the world’s first clean-label low GI White Bread.

Using PANATURA® GI is expected to add a marginal increase to the cost of production and the ingredients will comprise approximately 5-7% of the total flour mix.

The global white bread market is worth an estimated US$170 billion. Rollout will be in Australia first followed by Europe, North America China, India and the rest of Asia.

Overall, the results are highly promising for Hollista given the propensity for white bread consumption in western countries as well as the desire for healthier diets.



Proactive Investors is a global leader reporting financial news, media, research and hosts events for listed emerging growth companies and investors across four continents.



Tue, 12 Jan 2016 17:00:00 +1100
<![CDATA[News - Holista CollTech secures rights to ‘botox-like’ skin product ]]> Holista Colltech (ASX:HCT) has secured the exclusive rights for the Geltox Skin Science formulation that provides immediate short term reduction in facial expression lines as well as wrinkles.

This also reduces the appearance of these lines over the course of several months while eliminating the need for injections by a qualified professional.

Geltox Skin Science uses a combination of peptides and muscle relaxers that deeply penetrate skin and cause mild paralysis in select areas of the face similar to injections like Botox.

The technology is patent pending and was developed by Palma Biotech.

Holista will take the formulation into the Asian Pacific region.


Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

Tue, 28 Apr 2015 15:30:00 +1000
<![CDATA[News - Holista CollTech signs health food R&D agreement with Red Rooster operator ]]> Holista CollTech (ASX: HCT) has signed an exclusive two year research and development agreement with Quick Service Restaurant Holdings to develop healthier food without using chemical additives.

Under the agreement, Holista will supply its proprietary ingredients to Quick Service for joint research and development, with the aim of integrating Holista’s technology into Quick Service’s product pipeline.

Quick Service is the operator of the brands Red Rooster, Chicken Treat and Oporto.

The collaboration covers three patents; a potato chip that absorbs less fat during frying, a low-sodium salt and a low GI bread that digests and absorbs carbohydrates slowly, while releasing glucose more gradually into the bloodstream.

Holista will supply the natural ingredients for the three formulations, all of which are Asian ingredients listed by Australia’s Therapeutic Goods Administration and the United States Food and Drug Administration as “Generally regarded as safe”.

The company conducted initial research on the ingredients in the United Kingdom, India and Malaysia, and undertook validation at the University of Western Australia as part of the commercialisation project.

Holista will be responsible for all costs of research and development, which is currently expected to be about $820,000.

The company will receive milestone payments from Quick Service for a portion of these costs, and will seek research and development grants to assist in funding the costs.

The two companies have also agreed to a preferential supply arrangement for a further five years beyond the initial two year exclusivity agreement.

Holista is a biotechnology food ingredient specialist with operations in Australia and Asia.

Under the agreement, Holista will not sell its ingredients or products to any competitor of Quick Service within the Australian market.

Tue, 08 Nov 2011 11:31:00 +1100
<![CDATA[News - Holista Colltech in trading halt pending agreement on food product technologies ]]> Holista Colltech (ASX: HCT) has been granted a trading halt by the ASX pending the release of an announcement about the execution of a Heads of Agreement with a well known commercial food chain.

The agreement is for the delivery of the company's food product technologies.

The company expects to make an announcement on or before the commencement of trading on Monday 7 November, 2011.

Holista Colltech is a bio-industrial company committed to the development and commercialisation of ovine collagen for cosmetic and biomedical applications.

Thu, 03 Nov 2011 09:17:00 +1100